Inactive Instrument

BioTelemetry, Inc.

Equities

BEAT

US0906721065

Healthcare Facilities & Services

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors

November 07, 2018 at 04:49 pm EST

BioTelemetry, Inc. announced that Stephan Rietiker has been elected to BioTelemetry's Board of Directors. Dr. Rietiker was most recently the Chief Executive Officer of LifeWatch AG, until it was acquired by BioTelemetry in August 2017. Prior to becoming CEO of LifeWatch AG in 2014, Dr. Rietiker held executive roles at Roche, Boehringer Mannheim, Schering Plough, Covance and as CEO of Centerpulse.

Latest news about BioTelemetry, Inc.

Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	Feb. 29	CI
Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	23-07-26	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Health Care Services Select Industry Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Composite 1500	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care Services (Sub Ind)	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 1000	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P TMI Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Global BMI Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care	21-02-10	CI
BioTelemetry, Inc. Announces Board Changes	21-02-09	CI
BioTelemetry, Inc. Terminates Amended and Restated Credit Agreement	21-02-09	CI
Koninklijke Philips N : Royal Philips Completes Tender Offer to Acquire BioTelemetry at $72 per Share	21-02-09	MT
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from NASDAQ Composite Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Growth-Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Growth-Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Dynamic Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 3000 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2500 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Growth Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Completeness Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Comp Growth Index	21-02-09	CI

Chart BioTelemetry, Inc.

Duration

Period

More charts

Company Profile

BioTelemetry, Inc. is a remote medical technology company focused on delivery of health information. The Company is principally engaged in providing remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. The Company operates in two segments: Healthcare and Research. The Healthcare segment is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices. It offers cardiologists, electrophysiologists and primary care physicians a full spectrum of solutions, which provides them with a single source of cardiac monitoring services. The Research segment is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+19.28%	84.56B
CVS HEALTH CORPORATION	-26.95%	72.41B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.90%	27.73B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.75B
FRESENIUS SE & CO. KGAA	-0.64%	17.11B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	16.03B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.72B
NATERA, INC.	+69.96%	13.07B
FRESENIUS MEDICAL CARE AG	+6.56%	12.91B

Other Healthcare Facilities & Services